The Foundation's Liver and Pancreas Program concentrates on advancing focused ultrasound therapies for two of the most deadly, prevalent and difficult-to-treat cancers.
The Liver and Pancreas Program will be working in collaboration with the medical community to accelerate the development and adoption of focused ultrasound technology for the treatment of liver and pancreatic cancers.
In June 2012, the Foundation organized a world-class working group to spearhead an effort to treat liver cancer with focused ultrasound. Twenty experts and key opinion leaders in this area, including clinicians, scientists and industry leaders, met to discuss clinical, regulatory and technical barriers that must be addressed to make focused ultrasound liver treatments available to patients. The same group met again in October 2012. A paper outlining the path forward in terms of development and adoption was published in 2013 in the Journal of Therapeutic Ultrasound.
The Foundation has also supported innovative research done in the University of Washington to evaluate the effectiveness of focused ultrasound for enhancing drug delivery to pancreatic tumors.
Learn more information on liver cancer and the status of focused ultrasound technology in this area.
Learn more information on pancreatic cancer and the status of focused ultrasound technology in this area.